Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gore

Showing results (131-140 of 314) with videos related to

Pageof 32
Sort By:
Bone Marrow Transplantation|December 1, 1989
VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myelomaT J McElwain, M E Gore, M Meldrum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinomaV Hess, M W Verrill, C C Bomphray, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|January 1, 1995
Two decades of experience in the University of Washington Family Medicine Residency Network: practice differences between graduates in rural and urban locationsL M Baldwin, L G Hart, P A West, et al.
Health Services Research|March 29, 2000
A controlled time-series trial of clinical reminders: using computerized firm systems to make quality improvement research a routine part of mainstream practiceH I Goldberg, W E Neighbor, A D Cheadle, et al.
Journal of Clinical Epidemiology|February 13, 2001
Therapy naivete in the era of potent antiretroviral therapyL P Jacobson, M E Gore, S A Strathdee, et al.
British Journal of Cancer|June 1, 1995
Platinum-Taxol non-cross resistance in epithelial ovarian cancerM E Gore, N Preston, R P A'Hern, et al.
Clinical and Experimental Dermatology|September 29, 2015
A mitogen-activated protein kinase kinase inhibitor induced compound skin toxicity with oedema in metastatic malignant melanomaC L Thomas, P S Mortimer, J M Larkin, et al.
British Journal of Cancer|October 1, 1995
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experienceM E Gore, V Levy, G Rustin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 1998
Granulosa cell tumours of the ovary: demographics, survival and the management of advanced diseaseP Savage, D Constenla, C Fisher, et al.
Lancet (London, England)|January 18, 1992
Infectious complications of subcutaneous interleukin-2 and interferon-alphaA L Jones, I Cropley, M E O'Brien, et al.
Pageof 32

Showing results (131-140 of 314) with videos related to

Sort By:
Pageof 32
Bone Marrow Transplantation|December 1, 1989
VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myelomaT J McElwain, M E Gore, M Meldrum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinomaV Hess, M W Verrill, C C Bomphray, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|January 1, 1995
Two decades of experience in the University of Washington Family Medicine Residency Network: practice differences between graduates in rural and urban locationsL M Baldwin, L G Hart, P A West, et al.
Health Services Research|March 29, 2000
A controlled time-series trial of clinical reminders: using computerized firm systems to make quality improvement research a routine part of mainstream practiceH I Goldberg, W E Neighbor, A D Cheadle, et al.
Journal of Clinical Epidemiology|February 13, 2001
Therapy naivete in the era of potent antiretroviral therapyL P Jacobson, M E Gore, S A Strathdee, et al.
British Journal of Cancer|June 1, 1995
Platinum-Taxol non-cross resistance in epithelial ovarian cancerM E Gore, N Preston, R P A'Hern, et al.
Clinical and Experimental Dermatology|September 29, 2015
A mitogen-activated protein kinase kinase inhibitor induced compound skin toxicity with oedema in metastatic malignant melanomaC L Thomas, P S Mortimer, J M Larkin, et al.
British Journal of Cancer|October 1, 1995
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experienceM E Gore, V Levy, G Rustin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 1998
Granulosa cell tumours of the ovary: demographics, survival and the management of advanced diseaseP Savage, D Constenla, C Fisher, et al.
Lancet (London, England)|January 18, 1992
Infectious complications of subcutaneous interleukin-2 and interferon-alphaA L Jones, I Cropley, M E O'Brien, et al.
Pageof 32